Cargando…
The diagnosis, classification, and treatment of sarcoma in this era of artificial intelligence and immunotherapy
Soft‐tissue sarcomas (STS) represent a group of rare and heterogeneous tumors associated with several challenges, including incorrect or late diagnosis, the lack of clinical expertise, and limited therapeutic options. Digital pathology and radiomics represent transformative technologies that appear...
Autores principales: | Crombé, Amandine, Roulleau‐Dugage, Mathtieu, Italiano, Antoine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759765/ https://www.ncbi.nlm.nih.gov/pubmed/36260064 http://dx.doi.org/10.1002/cac2.12373 |
Ejemplares similares
-
New immunotherapy strategies for patients with sarcomas: highlights from the 2023 ASCO annual meeting
por: Roulleaux-Dugage, Matthieu, et al.
Publicado: (2023) -
Improving Immunotherapy Efficacy in Soft-Tissue Sarcomas: A Biomarker Driven and Histotype Tailored Review
por: Roulleaux Dugage, Matthieu, et al.
Publicado: (2021) -
Intensity harmonization techniques influence radiomics features and radiomics-based predictions in sarcoma patients
por: Crombé, Amandine, et al.
Publicado: (2020) -
Artificial intelligence for assisting cancer diagnosis and treatment in the era of precision medicine
por: Chen, Zi‐Hang, et al.
Publicado: (2021) -
Gene expression profiling improves prognostication by nomogram in patients with soft‐tissue sarcomas
por: Crombé, Amandine, et al.
Publicado: (2022)